Address: 13 Hanover Square, London, United Kingdom
Phone: +44 (0)20 7399 2760
Fax: +44 (0)20 7399 2761
Hikma is an international pharmaceutical company conducting operations through three businesses: generic pharmaceuticals, branded pharmaceuticals and injectable pharmaceuticals. The company sells 113 branded and non-branded generic pharmaceutical products in 34 countries worldwide. The majority of Hikma's operations are in the United States, the Middle East and North Africa Region and Europe.
Hikma Pharmaceuticals was the top gainer on the FTSE 100 today as its profit drop was smaller than expected. [...]
FTSE 100 pharma firm Hikma has cut its full-year sales guidance for its US generics business to roughly $600m, [...]
Pharmaceutical stocks – one of the few sectors that was thought to be privately if not publicly hoping for a [...]
The FTSE 100 ended the day at 6,894.6 points - 2.2 per cent higher, and within spitting distance of that 7,000 [...]
Hikma Pharmaceuticals is set to enter the FTSE 100 index as satellite firm Inmarsat drops to the FTSE 250. [...]
Hikma Pharmaceuticals’ share price plummeted 20 per cent this morning, after the drugmaker slashed its offer [...]
London-listed Hikma Pharmaceuticals received a boost this morning, after the FDA said it no longer had an issue [...]
The shake-up revealed as a result of the quarterly review of the FTSE 100 and 250 takes effect this morning. [...]
Tullow Oil and Afren are likely to slip out of their respective FTSE indexes after this week's quarterly review. [...]
Content tagged with "Hikma Pharmaceuticals"